|
GYG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.966800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.823400E-01 |
| Normal-vs-Stage2 |
1.445040E-01 |
| Normal-vs-Stage3 |
3.981000E-01 |
| Normal-vs-Stage4 |
2.680400E-01 |
| Stage1-vs-Stage2 |
3.174400E-01 |
| Stage1-vs-Stage3 |
5.895400E-01 |
| Stage1-vs-Stage4 |
3.565200E-01 |
| Stage2-vs-Stage3 |
4.804400E-01 |
| Stage2-vs-Stage4 |
7.758000E-02 |
| Stage3-vs-Stage4 |
1.217840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.012200E-01 |
| Normal-vs-AfricanAmerican |
2.586200E-01 |
| Normal-vs-Asian |
3.443400E-01 |
| Caucasian-vs-AfricanAmerican |
4.423000E-01 |
| Caucasian-vs-Asian |
6.349800E-01 |
| AfricanAmerican-vs-Asian |
7.589600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.969400E-01 |
| Normal-vs-Female |
2.377700E-02 |
| Male-vs-Female |
1.645720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.508000E-01 |
| Normal-vs-Extreme_Weight |
9.621800E-01 |
| Normal-vs-Obese |
4.481800E-01 |
| Normal-vs-Extreme_Obese |
9.976100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.498600E-01 |
| Normal_Weight-vs-Obese |
5.209000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.295790E-01 |
| Extreme_Weight-vs-Obese |
4.043600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.420180E-01 |
| Obese-vs-Extreme_Obese |
4.623700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.352400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.195200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.091800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.136000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.695800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.811400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.746400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.356200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.612600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.100200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.404600E-01 |
| Normal-VS-Type2 PRCC |
4.755800E-01 |
| Normal-VS-KIRP CIMP |
6.971400E-01 |
| Normal-VS-Unclassified PRCC |
4.760000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.848800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.224000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.908200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.366800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.954800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.196200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.980000E-01 |
| Normal-vs-N1 |
7.460800E-01 |
| Normal-vs-N2 |
1.963030E-01 |
| N0-vs-N1 |
7.827400E-01 |
| N0-vs-N2 |
3.478400E-01 |
| N1-vs-N2 |
2.105000E-01 |
|
|
